Nuvectis Pharma Announces FDA Clearance of IND for NXP800
21 juin 2022 08h15 HE
|
Nuvectis Pharma, Inc.
FORT LEE, NJ,, June 21, 2022 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (“Nuvectis”, “Company”), a biopharmaceutical company focused on the development of innovative precision medicines for the...